Published in J Geriatr Psychiatry Neurol on September 19, 2016
The projected effect of risk factor reduction on Alzheimer's disease prevalence. Lancet Neurol (2011) 8.15
Fragile X premutation tremor/ataxia syndrome: molecular, clinical, and neuroimaging correlates. Am J Hum Genet (2003) 5.51
Huntington's disease: from molecular pathogenesis to clinical treatment. Lancet Neurol (2011) 4.98
Untreated depression and hippocampal volume loss. Am J Psychiatry (2003) 4.84
Sleep-disordered breathing, hypoxia, and risk of mild cognitive impairment and dementia in older women. JAMA (2011) 4.83
Neuropathology of fragile X-associated tremor/ataxia syndrome (FXTAS). Brain (2005) 3.99
Changes in cognitive functioning following treatment of late-life depression. Am J Psychiatry (2000) 2.70
Predictors of dementia in Parkinson disease: a prospective cohort study. Neurology (2014) 2.44
Penetrance of FMR1 premutation associated pathologies in fragile X syndrome families. Eur J Hum Genet (2009) 2.16
Age-dependent cognitive changes in carriers of the fragile X syndrome. Cortex (2007) 2.10
The course of geriatric depression with "reversible dementia": a controlled study. Am J Psychiatry (1993) 1.92
Risk factors and preventive interventions for Alzheimer disease: state of the science. Arch Neurol (2011) 1.85
Psychiatric phenotype of the fragile X-associated tremor/ataxia syndrome (FXTAS) in males: newly described fronto-subcortical dementia. J Clin Psychiatry (2006) 1.80
Lifetime prevalence of mood and anxiety disorders in fragile X premutation carriers. J Clin Psychiatry (2010) 1.79
Progression of tremor and ataxia in male carriers of the FMR1 premutation. Mov Disord (2007) 1.77
Impairment in the cognitive functioning of men with fragile X-associated tremor/ataxia syndrome (FXTAS). J Neurol Sci (2006) 1.75
Selective executive markers of at-risk profiles associated with the fragile X premutation. Neurology (2011) 1.75
CGG repeat length correlates with age of onset of motor signs of the fragile X-associated tremor/ataxia syndrome (FXTAS). Am J Med Genet B Neuropsychiatr Genet (2007) 1.66
Treatment of fragile X-associated tremor ataxia syndrome (FXTAS) and related neurological problems. Clin Interv Aging (2008) 1.57
Very early detection of Alzheimer neuropathology and the role of brain reserve in modifying its clinical expression. J Geriatr Psychiatry Neurol (2005) 1.48
Neuropathological, clinical and molecular pathology in female fragile X premutation carriers with and without FXTAS. Genes Brain Behav (2012) 1.44
FXTAS: new insights and the need for revised diagnostic criteria. Neurology (2012) 1.39
A neuropsychological investigation of male premutation carriers of fragile X syndrome. Neuropsychologia (2004) 1.38
Impact of the Fragile X mental retardation 1 (FMR1) gene premutation on neuropsychiatric functioning in adult males without fragile X-associated Tremor/Ataxia syndrome: a controlled study. Am J Med Genet B Neuropsychiatr Genet (2008) 1.34
Dementia in fragile X-associated tremor/ataxia syndrome (FXTAS): comparison with Alzheimer's disease. Am J Med Genet B Neuropsychiatr Genet (2008) 1.32
Lifespan changes in working memory in fragile X premutation males. Brain Cogn (2008) 1.29
Sleep apnea in fragile X premutation carriers with and without FXTAS. Am J Med Genet B Neuropsychiatr Genet (2011) 1.14
Penetrance of marked cognitive impairment in older male carriers of the FMR1 gene premutation. J Med Genet (2009) 1.09
Dementia with mood symptoms in a fragile X premutation carrier with the fragile X-associated tremor/ataxia syndrome: clinical intervention with donepezil and venlafaxine. J Neuropsychiatry Clin Neurosci (2006) 1.08
New clinical findings in the fragile X-associated tremor ataxia syndrome (FXTAS). Neurogenetics (2011) 1.06
Interaction between genetic and environmental risk factors for Alzheimer's disease: a reanalysis of case-control studies. Genet Epidemiol (1994) 1.05
Hypertension in FMR1 premutation males with and without fragile X-associated tremor/ataxia syndrome (FXTAS). Am J Med Genet A (2012) 1.00
Fragile X-associated tremor/ataxia syndrome. Ann N Y Acad Sci (2015) 0.98
Age-dependent structural connectivity effects in fragile x premutation. Arch Neurol (2012) 0.97
Symptomatic treatment in the fragile X-associated tremor/ataxia syndrome. Mov Disord (2006) 0.97
Fragile X premutation in a woman with cognitive impairment, tremor, and history of premature ovarian failure. Alzheimer Dis Assoc Disord (2007) 0.91
Abnormal N400 word repetition effects in fragile X-associated tremor/ataxia syndrome. Brain (2010) 0.90
Reduced telomere length in older men with premutation alleles of the fragile X mental retardation 1 gene. Am J Med Genet A (2008) 0.90
Fragile X associated tremor/ataxia syndrome (FXTAS) with dementia in a female harbouring FMR1 premutation. J Neurol Neurosurg Psychiatry (2008) 0.90
Atypical clinical course of FXTAS: rapidly progressive dementia as the major symptom. Neurology (2007) 0.87
PSYCHIATRIC DISORDERS ASSOCIATED WITH FXTAS. Curr Psychiatry Rev (2015) 0.87
Memantine for fragile X-associated tremor/ataxia syndrome: a randomized, double-blind, placebo-controlled trial. J Clin Psychiatry (2014) 0.86
Motor and mental dysfunction in mother-daughter transmitted FXTAS. Neurology (2010) 0.86
Functional status of men with the fragile X premutation, with and without the tremor/ataxia syndrome (FXTAS). Int J Geriatr Psychiatry (2009) 0.85
Assessment of patient and caregiver needs in fragile X-associated tremor/ataxia syndrome by utilizing Q-sort methodology. Aging Ment Health (2010) 0.85
Fragile X dementia Parkinsonism Syndrome (FXDPS). Cogn Behav Neurol (2010) 0.84
Ages of Onset of Mood and Anxiety Disorders in Fragile X Premutation Carriers. Curr Psychiatry Rev (2013) 0.84
Conversion disorder in women with the FMR1 premutation. Am J Med Genet A (2009) 0.81
Fragile X-associated tremor/ataxia syndrome: influence of the FMR1 gene on motor fiber tracts in males with normal and premutation alleles. JAMA Neurol (2013) 0.81
High apolipoprotein E4 allele frequency in FXTAS patients. Genet Med (2013) 0.79
COGNITIVE DYSFUNCTION IN FMR1 PREMUTATION CARRIERS. Curr Psychiatry Rev (2013) 0.79
Obstructive sleep apnea and neurocognitive performance: the role of cortisol. Sleep Med (2013) 0.78
Apolipoprotein E genotype and cerebrovascular alterations can influence conversion to dementia in patients with mild cognitive impairment. J Alzheimers Dis (2014) 0.77
Chronic Depressive Symptomatology in Mild Cognitive Impairment Is Associated with Frontal Atrophy Rate which Hastens Conversion to Alzheimer Dementia. Am J Geriatr Psychiatry (2015) 0.76
Parkinson's disease dementia: Diagnostic criteria and risk factor review. J Clin Exp Neuropsychol (2015) 0.76
ERP abnormalities elicited by word repetition in fragile X-associated tremor/ataxia syndrome (FXTAS) and amnestic MCI. Neuropsychologia (2014) 0.76